Baseimmune

London, United Kingdom · Founded 2019 · Privately Held (backing)

Developer of a platform designed for pathogen analysis to create antigen and vaccine designs. Baseimmune is based in London, United Kingdom and was founded in 2019. It has raised $16.8 million.

Last price · $/share
—
Implied valuation
—
Total raised
$16.8M
Last round
—

Who backs Baseimmune?

15 investors
InvestorType
Tiny Supercomputer Investment CompanyVenture capital
Cherry VenturesVenture capital
IQ Capital PartnersVenture capital
Hoxton VenturesOther
MSD Global Health Innovation FundVenture capital
Maki.vcVenture capital
LifeArcOther
Beast Ventures—
BioIndustry Association—
Creator Fund—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Baseimmune investors

15 investors are on record for Baseimmune, including Tiny Supercomputer Investment Company, Cherry Ventures, IQ Capital Partners and Hoxton Ventures. By type, the record holds 5 venture capital firms.

Free account
More of Baseimmune with a free account
  • ·The complete investor list: 15 names
  • ·Watch Baseimmune: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Baseimmune. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View